From: Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens
Tissue processing variability
RNA processing variability
Total variability
Total SD
Site
Within block/process
0.10
7.72
0.47
8.29
2.9